Simone Braggio

1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines:  A Series of Potent and Selective Dopamine D₃Receptor Antagonists

Fabrizio Micheli, Giorgio Bonanomi, Frank E. Blaney et al. · Journal of Medicinal Chemistry · 2007 · 83 citations · Full text

6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor

Fabrizio Micheli, Paolo Cavanni, Daniele Andreotti et al. · Journal of Medicinal Chemistry · 2010 · 68 citations · Full text

Pharmacotherapy, New Series, Heterocycle Chemistry +16

1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D₃Receptor Antagonists

Fabrizio Micheli, Luca Arista, Giorgio Bonanomi et al. · Journal of Medicinal Chemistry · 2009 · 55 citations · Full text

1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors

Fabrizio Micheli, Paolo Cavanni, Roberto Arban et al. · Journal of Medicinal Chemistry · 2010 · 51 citations · Full text

Medicinal Chemistry, Heterocyclic, Pharmacological Study +15

Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders

Romano Di Fabio, Annalisa Pellacani, Stefania Faedo et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 51 citations · Full text

Sleep Disorders, Sleep, Sleep Disorder +10